Cite
Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study.
MLA
Mateescu, Radu Bogdan, et al. “Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study.” Journal of Gastrointestinal & Liver Diseases, vol. 32, no. 4, Dec. 2023, pp. 444–51. EBSCOhost, https://doi.org/10.15403/jgld-5128.
APA
Mateescu, R. B., Gheorghe, C., Trifan, A. V., Saftoiu, A., Seicean, A., Diculescu, M. M., Banciu, C., Gheorghe, L. S., Busuioc, B., Goldis, A., Dobru, D., Fratila, O., Eugen, D., Bataga, S., Constantinescu, G., Gheonea, D., Tantau, A., Jinga, M., Brisc, C., & Prelipcean, C. C. (2023). Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study. Journal of Gastrointestinal & Liver Diseases, 32(4), 444–451. https://doi.org/10.15403/jgld-5128
Chicago
Mateescu, Radu Bogdan, Cristian Gheorghe, Anca Victorita Trifan, Adrian Saftoiu, Andrada Seicean, Mihai Mircea Diculescu, Christian Banciu, et al. 2023. “Safety, Efficacy and Persistence of Advanced Therapies in Inflammatory Bowel Disease: Results from ORIGINS. A Retrospective Observational Study.” Journal of Gastrointestinal & Liver Diseases 32 (4): 444–51. doi:10.15403/jgld-5128.